Idoxuridine
From Wikipedia, the free encyclopedia
Idoxuridine
|
|
Systematic (IUPAC) name | |
1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl) oxolan-2-yl]- 5-iodo-pyrimidine-2,4-dione | |
Identifiers | |
CAS number | 54-42-2 |
ATC code | D06BB01 J05AB02, S01AD01 |
PubChem | 5905 |
DrugBank | APRD00504 |
Chemical data | |
Formula | C9H11N2IO5 |
Mol. weight | 354.099 g/mol |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | ? |
Idoxuridine is an anti-herpesvirus antiviral drug.
[edit] External links
- Seth A, Misra A, Umrigar D (2004). "Topical liposomal gel of idoxuridine for the treatment of herpes simplex: pharmaceutical and clinical implications.". Pharm Dev Technol 9 (3): 277-89. PMID 15458233.
- Otto S. "Radiopharmaceuticals (Strontium 89) and radiosensitizers (idoxuridine).". J Intraven Nurs 21 (6): 335-7. PMID 10392098.
- Fauth E, Zankl H (1999). "Comparison of spontaneous and idoxuridine-induced micronuclei by chromosome painting.". Mutat Res 440 (2): 147-56. PMID 10209337.
Antivirals (primarily J05A, also S01AD and D06BB) edit | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|